Land: USA
Språk: engelsk
Kilde: NLM (National Library of Medicine)
PROPOFOL (UNII: YI7VU623SF) (PROPOFOL - UNII:YI7VU623SF)
RX PHARMA-PACK, INC.
PROPOFOL
PROPOFOL 10 mg in 1 mL
PRESCRIPTION DRUG
DIPRIVAN is an IV general anesthetic and sedation drug that can be used as described in the table below. Table 3. Indications for DIPRIVAN Safety, effectiveness and dosing guidelines for DIPRIVAN have not been established for MAC Sedation in the pediatric population; therefore, it is not recommended for this use (see PRECAUTIONS, Pediatric Use ). DIPRIVAN is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations. In the Intensive Care Unit (ICU), DIPRIVAN can be administered to intubated, mechanically ventilated adult patients to provide continuous sedation and control of stress responses only by persons skilled in the medical management of critically ill patients and trained in cardiovascular resuscitation and airway management. DIPRIVAN is not indicated for use in Pediatric ICU sedation since the safety of this regimen has not been established (see PR
DIPRIVAN (propofol) Injectable Emulsion, USP Vials 10 mL ready-to-use single- patient infusion vial in packages of ten. 20 mL ready-to-use single- patient infusion vial in packages of ten. 50 mL ready-to-use single- patient infusion vial in packages of twenty. Propofol undergoes oxidative degradation, in the presence of oxygen, and is therefore packaged under nitrogen to eliminate this degradation path. Store between 4° to 25°C (40° to 77°F). Do not freeze. Shake well before use. All trademarks are the property of Fresenius Kabi USA, LLC. Manufactured for: Fresenius Kabi Logo Lake Zurich, IL 60047 www.fresenius-kabi.com/us Revised: December 2017
New Drug Application
ANESTHESIA S/I-60- PROPOFOL, STERILE ISOPROPYL ALCOHOL RX PHARMA-PACK, INC. ---------- ANESTHESIA S-I-60 DIPRIVAN - PROPOFOL INJECTION, EMULSION DIPRIVAN INJECTABLE EMULSION, USP 10 MG PER ML FRESENIUS KABI USA, LLC FOR INTRAVENOUS ADMINISTRATION _Strict aseptic technique must always be maintained during handling. DIPRIVAN is a single access_ _parenteral product (single patient infusion vial) which contains 0.005% disodium edetate (EDTA) to inhibit_ _the rate of growth of microorganisms, for up to 12 hours, in the event of accidental extrinsic contamination._ _However, DIPRIVAN can still support the growth of microorganisms, as it is not an antimicrobially_ _preserved product under USP standards. Do not use if contamination is suspected. Discard unused drug_ _product as directed within the required time limits. There have been reports in which failure to use aseptic_ _technique when handling DIPRIVAN was associated with microbial contamination of the product and with_ _fever, infection/sepsis, other life-threatening illness, and/or death. _ _There have been reports, in the literature and other public sources, of the transmission of bloodborne_ _pathogens (such as Hepatitis B, Hepatitis C, and HIV) from unsafe injection practices, and use of propofol_ _vials intended for single use on multiple persons. DIPRIVAN vials are never to be accessed more than once_ _or used on more than one person. (See _WARNINGS _ and _DOSAGE AND ADMINISTRATION, Handling Procedures). DESCRIPTION DIPRIVAN (Propofol) Injectable Emulsion, USP is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration. Propofol is chemically described as 2,6- diisopropylphenol. The structural formula is: DIPRIVAN STRUCTURAL FORMULA Propofol is slightly soluble in water and, thus, is formulated in a white, oil-in-water emulsion. The pKa is 11. The octanol/water partition coefficient for propofol is 6761:1 at a pH of 6 to 8.5. In addition to the active component, propofol, the formulation also contains soybean o Les hele dokumentet